Novo Nordisk and AWS create AI co-innovation hub in London
Novo Nordisk will unite teams with Amazon Web Services through a new London co-innovation hub to deepen its AI push in drug discovery. The collaboration uses services such as Amazon Bio Discovery and Amazon Bedrock, aiming to accelerate development and expand AI across research and development, commercial operations, and information technology. AWS becomes Novo Nordisk’s preferred cloud and strategic AI partner under the Aug. 10 agreement.